X T L BIOPHARMACEUTICALS LTD

Inactive Instrument

Press Releases X T L Biopharmaceuticals Ltd Deutsche Boerse AG

Equities

US98386D2080

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

06-05	XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy	MT
06-05	XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

XTL Biopharmaceuticals : Immediate Report of Meeting	06-12	PU
XTL Biopharmaceuticals : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 22, 2024 Form 6 K	06-12	PU
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	04-02	PU
XTL Biopharmaceuticals : Immediate Report of Meeting	03-21	PU
XTL Biopharmaceuticals : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 30, 2024 - Form 6-K	03-21	PU
XTL To Aquire The Social Proxy	03-20	AQ
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	11-15	PU
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	20/10/23	AQ
XTL Biopharmaceuticals : OPERATING AND FINANCIAL REVIEW AND PROSPECTS (Form 6-K)	24/08/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer